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The prognosis of adult acute leukaemia has improved with better chemotherapy and the use of newer antibiotics for the infective problems of neutropenia. Pulmonary complications are second in importance only to disseminated infection as the major cause of morbidity and mortality, though they are themselves frequently accompanied by septicaemia. ' 2 The range of pulmonary disease includes Gram negative and Gram positive pneumonias, opportunistic infections particularly with fungi and Pneumocystis carinii, leukaemic infiltration, pulmonary haemorrhage and oedema; two or more of these processes may be present.3 '4 Opinion is divided on whether the lung or the gastrointestinal tract is the more frequent source of septicaemia in neutropenic patients. 256 The reported mortality rate associated with pulmonary complications is around 60-65%. 8 Death may occur within a few days of the appearance of an abnormality on a chest radiograph. 9 In vivo and postmortem studies agree that Gram negative organisms are the commonest cause of pneumonia, though Gram positive bacteria and anaerobes are also important.'-3 0 ' The incidence of any one organism may vary from hospital to hospital, depending on the particular bacterial population prevalent at the time. The incidence of fungal pneumonia has been found to be as high as 25%8 in a series which included postmortem data, but a figure of around 12%1O may be more representative. Although 19% of the infiltrates in a recent series from the United States" were due to Aspergillus or Candida, this was not an unselected consecutive series. Pneumocystis carinii pneumonia occurs less often in adults than in children with acute leukaemia, but it is a well documented occurrence. '2 13 for this or were the coliforms the primary bacterial infection, the patient being investigated only because of a failure to respond to the initial antibiotic regime? If the findings of this study are confirmed and if further bacterial investigations support the contention that the coliforms were secondary colonisers, then the empirical antibiotic approach for respiratory infection in these circumstances must be reassessed.
Though there may be some benefit to the patient from early transtracheal aspiration, it is difficult to find evidence of benefit from the more invasive procedures in terms of a lower mortality rate, even where a specific diagnosis was made and treatment altered. '7 182930 One recent study of the usefulness of transbronchial biopsy in a mixed group of immunosuppressed patients showed that, even though 65% had a change of therapeutic approach as a result of the biopsy, making a specific diagnosis did not improve survival. 29 The matter is unlikely to become any clearer until a major prospective study in adult leukaemia is undertaken that compares an unselected consecutive series managed either (1) by empirical treatment, possibly preceded by transtracheal aspiration, with the option of a later invasive procedure if progress is not satisfactory, or (2) Pulmonary infiltrates in adult acute leukaemia by an early initial biopsy procedure followed by the appropriate treatment indicated. Any such study would encounter the problem of how to manage the seriously ill, hypoxaemic and thrombocytopenic patient who may present during the night or weekend; it would be difficult to withhold antibiotic treatment while arrangements were made for an invasive biopsy procedure.
An attempt to rationalise the management of this clinical condition came from the findings of a retrospective review analysing the aetiology of episodes of pulmonary infiltration and the extent of radiologically apparent disease in 139 adults with leukaemia, of whom 85 had acute leukaemia." In those with local radiological abnormalities 74% of the infiltrations were infective, 87% of the infections being bacterial; opportunistic infections occurred in only 13% of episodes. In diffuse radiological disease 65% of episodes were not infective, though 93% of the infective episodes were opportunistic. On this evidence biopsy procedures to diagnose opportunistic infections would seem most appropriate in patients with diffuse changes in whom there was reason to suspect a predominantly infectious aetiology rather than pulmonary haemorrhage, leukaemic infiltration, or pulmonary oedema. The main criticisms of this important contribution are the loose definition of the two radiological groups and the influence of delay in referral from another hospital that may have resulted in selection of patients-particularly in the "diffuse" group since the mortarlty in patients with diffuse changes affecting all lung zones is high in the first 48 hours after the first detection of an abnormal chest radiograph. 9 A scheme of initial management to be considered might be: (1) The routine use of transtracheal aspiration as soon as possible after the onset of fever and respiratory symptoms, whether there are radiological abnormalities or not. (2) The administration of broad spectrum antibiotic combinations until the culture results are available, transfusion of platelets if the count is less than 10 x 109/l, and the addition of diuretic treatment if pulmonary oedema is suspected. (3) The use of transbronchial biopsy in patients with " local" radiological changes if progress is not satisfactory after 48 hours. (4) Empirical treatment, which should probably include high dose co-trimoxazole and amphotericin B, in patients with diffuse changes, a lung biopsy being performed in the first 24 hours if possible, depending on the clinical state of the patient. Physicians require some hard evidence from clinical trials that a lung biopsy is likely to affect outcome in these circumstances.
Until proper trials are designed to compare different patterns of management it is doubtful if further progress can be made in improving the prog-649 nosis of lung disease accompanying adult acute leukaemia.
